Literature DB >> 16581770

Subcellular targeting of p33ING1b by phosphorylation-dependent 14-3-3 binding regulates p21WAF1 expression.

Wei Gong1, Michael Russell, Keiko Suzuki, Karl Riabowol.   

Abstract

ING1 is a type II tumor suppressor that affects cell growth, stress signaling, apoptosis, and DNA repair by altering chromatin structure and regulating transcription. Decreased ING1 expression is seen in several human cancers, and mislocalization has been noted in diverse types of cancer cells. Aberrant targeting may, therefore, functionally inactivate ING1. Bioinformatics analysis identified a sequence between the nuclear localization sequence and plant homeodomain domains of ING1 that closely matched the binding motif of 14-3-3 proteins that target cargo proteins to specific subcellular locales. We find that the widely expressed p33(ING1b) splicing isoform of ING1 interacts with members of the 14-3-3 family of proteins and that this interaction is regulated by the phosphorylation status of ING1. 14-3-3 binding resulted in significant amounts of p33(ING1b) protein being tethered in the cytoplasm. As shown previously, ectopic expression of p33(ING1b) increased levels of the p21(Waf1) cyclin-dependent kinase inhibitor upon UV-induced DNA damage. Overexpression of 14-3-3 inhibited the up-regulation of p21(Waf1) by p33(ING1b), consistent with the idea that mislocalization blocks at least one of ING1's biological activities. These data support the idea that the 14-3-3 proteins play a crucial role in regulating the activity of p33(ING1b) by directing its subcellular localization.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16581770      PMCID: PMC1446971          DOI: 10.1128/MCB.26.8.2947-2954.2006

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  53 in total

1.  Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation

Authors: 
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

2.  UV induces nucleolar translocation of ING1 through two distinct nucleolar targeting sequences.

Authors:  M Scott; F M Boisvert; D Vieyra; R N Johnston; D P Bazett-Jones; K Riabowol
Journal:  Nucleic Acids Res       Date:  2001-05-15       Impact factor: 16.971

Review 3.  How do 14-3-3 proteins work?-- Gatekeeper phosphorylation and the molecular anvil hypothesis.

Authors:  Michael B Yaffe
Journal:  FEBS Lett       Date:  2002-02-20       Impact factor: 4.124

4.  Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine.

Authors:  A J Muslin; J W Tanner; P M Allen; A S Shaw
Journal:  Cell       Date:  1996-03-22       Impact factor: 41.582

5.  Adenovirus-mediated transfer of p33ING1 with p53 drastically augments apoptosis in gliomas.

Authors:  N Shinoura; Y Muramatsu; M Nishimura; Y Yoshida; A Saito; T Yokoyama; T Furukawa; A Horii; M Hashimoto; A Asai; T Kirino; H Hamada
Journal:  Cancer Res       Date:  1999-11-01       Impact factor: 12.701

6.  The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control.

Authors:  I Garkavtsev; I A Grigorian; V S Ossovskaya; M V Chernov; P M Chumakov; A V Gudkov
Journal:  Nature       Date:  1998-01-15       Impact factor: 49.962

7.  Identification of 14-3-3zeta as a protein kinase B/Akt substrate.

Authors:  David W Powell; Madhavi J Rane; Qingdan Chen; Saurabh Singh; Kenneth R McLeish
Journal:  J Biol Chem       Date:  2002-04-15       Impact factor: 5.157

8.  Loss of nuclear expression of the p33(ING1b) inhibitor of growth protein in childhood acute lymphoblastic leukaemia.

Authors:  G S Nouman; J J Anderson; K M Wood; J Lunec; A G Hall; M M Reid; B Angus
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

9.  Expression of p33ING1 mRNA and chemosensitivity in brain tumor cells.

Authors:  G Tallen; K Riabowol; J E Wolff
Journal:  Anticancer Res       Date:  2003 Mar-Apr       Impact factor: 2.480

10.  Loss of serum response element-binding activity and hyperphosphorylation of serum response factor during cellular aging.

Authors:  P W Atadja; K F Stringer; K T Riabowol
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

View more
  31 in total

Review 1.  The ING family tumor suppressors: from structure to function.

Authors:  Almass-Houd Aguissa-Touré; Ronald P C Wong; Gang Li
Journal:  Cell Mol Life Sci       Date:  2010-08-29       Impact factor: 9.261

Review 2.  Chaperone receptors: guiding proteins to intracellular compartments.

Authors:  Verena Kriechbaumer; Ottilie von Löffelholz; Ben M Abell
Journal:  Protoplasma       Date:  2011-04-03       Impact factor: 3.356

Review 3.  ING1 and ING2: multifaceted tumor suppressor genes.

Authors:  Claire Guérillon; Delphine Larrieu; Rémy Pedeux
Journal:  Cell Mol Life Sci       Date:  2013-02-15       Impact factor: 9.261

4.  SUMOylation of the ING1b tumor suppressor regulates gene transcription.

Authors:  Shankha Satpathy; Claire Guérillon; Tae-Sun Kim; Nicolas Bigot; Satbir Thakur; Shirin Bonni; Karl Riabowol; Rémy Pedeux
Journal:  Carcinogenesis       Date:  2014-06-05       Impact factor: 4.944

5.  Cytoplasmic expression of p33(ING1b) is correlated with tumorigenesis and progression of human esophageal squamous cell carcinoma.

Authors:  Zhen-Long Zhu; Bao-Yong Yan; Yu Zhang; Yan-Hong Yang; Zheng-Min Wang; Hong-Zhen Zhang; Ming-Wei Wang; Xiang-Hong Zhang; Xiao-Feng Sun
Journal:  Oncol Lett       Date:  2012-10-22       Impact factor: 2.967

6.  REAP: A two minute cell fractionation method.

Authors:  Keiko Suzuki; Pinaki Bose; Rebecca Yy Leong-Quong; Donald J Fujita; Karl Riabowol
Journal:  BMC Res Notes       Date:  2010-11-10

Review 7.  The ING gene family in the regulation of cell growth and tumorigenesis.

Authors:  Andrew H Coles; Stephen N Jones
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

Review 8.  INGs are potential drug targets for cancer.

Authors:  Runyun Zhang; Jianhua Jin; Juanjuan Shi; Yongzhong Hou
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-20       Impact factor: 4.553

Review 9.  14-3-3 proteins, FHA domains and BRCT domains in the DNA damage response.

Authors:  Duaa H Mohammad; Michael B Yaffe
Journal:  DNA Repair (Amst)       Date:  2009-05-29

Review 10.  Reviewing the current classification of inhibitor of growth family proteins.

Authors:  Motoko Unoki; Kensuke Kumamoto; Seiichi Takenoshita; Curtis C Harris
Journal:  Cancer Sci       Date:  2009-04-28       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.